Copyright Reports & Markets. All rights reserved.

Global Amino Acid Metabolism Disorder Drug Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Arginine
    • 1.2.3 Folic Acid
    • 1.2.4 Vitamin B6 & B12
    • 1.2.5 Thiamine
    • 1.2.6 Vitamin D
    • 1.2.7 Betaine
    • 1.2.8 Carglumic Acid
    • 1.2.9 Sapropterin Dihydrochloride
    • 1.2.10 Others
  • 1.3 Market by Application
    • 1.3.1 Global Amino Acid Metabolism Disorder Drug Market Share by Application: 2020 VS 2026
    • 1.3.2 Phenylketonuria
    • 1.3.3 Maple Syrup Urine Disease
    • 1.3.4 Argininosuccinic Acidemia
    • 1.3.5 Citrullinemia
    • 1.3.6 Homocystinuria
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Amino Acid Metabolism Disorder Drug Market Perspective (2015-2026)
  • 2.2 Global Amino Acid Metabolism Disorder Drug Growth Trends by Regions
    • 2.2.1 Amino Acid Metabolism Disorder Drug Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Amino Acid Metabolism Disorder Drug Historic Market Share by Regions (2015-2020)
    • 2.2.3 Amino Acid Metabolism Disorder Drug Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Amino Acid Metabolism Disorder Drug Players by Market Size
    • 3.1.1 Global Top Amino Acid Metabolism Disorder Drug Players by Revenue (2015-2020)
    • 3.1.2 Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Players (2015-2020)
  • 3.2 Global Amino Acid Metabolism Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Amino Acid Metabolism Disorder Drug Revenue
  • 3.4 Global Amino Acid Metabolism Disorder Drug Market Concentration Ratio
    • 3.4.1 Global Amino Acid Metabolism Disorder Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Amino Acid Metabolism Disorder Drug Revenue in 2019
  • 3.5 Key Players Amino Acid Metabolism Disorder Drug Area Served
  • 3.6 Key Players Amino Acid Metabolism Disorder Drug Product Solution and Service
  • 3.7 Date of Enter into Amino Acid Metabolism Disorder Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Amino Acid Metabolism Disorder Drug Breakdown Data by Type (2015-2026)

  • 4.1 Global Amino Acid Metabolism Disorder Drug Historic Market Size by Type (2015-2020)
  • 4.2 Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Type (2021-2026)

5 Amino Acid Metabolism Disorder Drug Breakdown Data by Application (2015-2026)

  • 5.1 Global Amino Acid Metabolism Disorder Drug Historic Market Size by Application (2015-2020)
  • 5.2 Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Amino Acid Metabolism Disorder Drug Market Size (2015-2026)
  • 6.2 North America Amino Acid Metabolism Disorder Drug Market Size by Type (2015-2020)
  • 6.3 North America Amino Acid Metabolism Disorder Drug Market Size by Application (2015-2020)
  • 6.4 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Amino Acid Metabolism Disorder Drug Market Size (2015-2026)
  • 7.2 Europe Amino Acid Metabolism Disorder Drug Market Size by Type (2015-2020)
  • 7.3 Europe Amino Acid Metabolism Disorder Drug Market Size by Application (2015-2020)
  • 7.4 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Amino Acid Metabolism Disorder Drug Market Size (2015-2026)
  • 8.2 China Amino Acid Metabolism Disorder Drug Market Size by Type (2015-2020)
  • 8.3 China Amino Acid Metabolism Disorder Drug Market Size by Application (2015-2020)
  • 8.4 China Amino Acid Metabolism Disorder Drug Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Amino Acid Metabolism Disorder Drug Market Size (2015-2026)
  • 9.2 Japan Amino Acid Metabolism Disorder Drug Market Size by Type (2015-2020)
  • 9.3 Japan Amino Acid Metabolism Disorder Drug Market Size by Application (2015-2020)
  • 9.4 Japan Amino Acid Metabolism Disorder Drug Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Amino Acid Metabolism Disorder Drug Market Size (2015-2026)
  • 10.2 Southeast Asia Amino Acid Metabolism Disorder Drug Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Amino Acid Metabolism Disorder Drug Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Amino Acid Metabolism Disorder Drug Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Company Details
    • 11.1.2 GlaxoSmithKline Business Overview
    • 11.1.3 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Introduction
    • 11.1.4 GlaxoSmithKline Revenue in Amino Acid Metabolism Disorder Drug Business (2015-2020))
    • 11.1.5 GlaxoSmithKline Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Amino Acid Metabolism Disorder Drug Introduction
    • 11.2.4 Pfizer Revenue in Amino Acid Metabolism Disorder Drug Business (2015-2020)
    • 11.2.5 Pfizer Recent Development
  • 11.3 AMINO
    • 11.3.1 AMINO Company Details
    • 11.3.2 AMINO Business Overview
    • 11.3.3 AMINO Amino Acid Metabolism Disorder Drug Introduction
    • 11.3.4 AMINO Revenue in Amino Acid Metabolism Disorder Drug Business (2015-2020)
    • 11.3.5 AMINO Recent Development
  • 11.4 Merck
    • 11.4.1 Merck Company Details
    • 11.4.2 Merck Business Overview
    • 11.4.3 Merck Amino Acid Metabolism Disorder Drug Introduction
    • 11.4.4 Merck Revenue in Amino Acid Metabolism Disorder Drug Business (2015-2020)
    • 11.4.5 Merck Recent Development
  • 11.5 Recordati
    • 11.5.1 Recordati Company Details
    • 11.5.2 Recordati Business Overview
    • 11.5.3 Recordati Amino Acid Metabolism Disorder Drug Introduction
    • 11.5.4 Recordati Revenue in Amino Acid Metabolism Disorder Drug Business (2015-2020)
    • 11.5.5 Recordati Recent Development
  • 11.6 DSM
    • 11.6.1 DSM Company Details
    • 11.6.2 DSM Business Overview
    • 11.6.3 DSM Amino Acid Metabolism Disorder Drug Introduction
    • 11.6.4 DSM Revenue in Amino Acid Metabolism Disorder Drug Business (2015-2020)
    • 11.6.5 DSM Recent Development
  • 11.7 Sanofi
    • 11.7.1 Sanofi Company Details
    • 11.7.2 Sanofi Business Overview
    • 11.7.3 Sanofi Amino Acid Metabolism Disorder Drug Introduction
    • 11.7.4 Sanofi Revenue in Amino Acid Metabolism Disorder Drug Business (2015-2020)
    • 11.7.5 Sanofi Recent Development
  • 11.8 Kyowa Hakko Kirin
    • 11.8.1 Kyowa Hakko Kirin Company Details
    • 11.8.2 Kyowa Hakko Kirin Business Overview
    • 11.8.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Introduction
    • 11.8.4 Kyowa Hakko Kirin Revenue in Amino Acid Metabolism Disorder Drug Business (2015-2020)
    • 11.8.5 Kyowa Hakko Kirin Recent Development
  • 11.9 BioMarin
    • 11.9.1 BioMarin Company Details
    • 11.9.2 BioMarin Business Overview
    • 11.9.3 BioMarin Amino Acid Metabolism Disorder Drug Introduction
    • 11.9.4 BioMarin Revenue in Amino Acid Metabolism Disorder Drug Business (2015-2020)
    • 11.9.5 BioMarin Recent Development
  • 11.10 Swedish Orphan Biovitrum
    • 11.10.1 Swedish Orphan Biovitrum Company Details
    • 11.10.2 Swedish Orphan Biovitrum Business Overview
    • 11.10.3 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Introduction
    • 11.10.4 Swedish Orphan Biovitrum Revenue in Amino Acid Metabolism Disorder Drug Business (2015-2020)
    • 11.10.5 Swedish Orphan Biovitrum Recent Development
  • 11.11 Shine Star (Hubei) Biological Engineering
    • 10.11.1 Shine Star (Hubei) Biological Engineering Company Details
    • 10.11.2 Shine Star (Hubei) Biological Engineering Business Overview
    • 10.11.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Introduction
    • 10.11.4 Shine Star (Hubei) Biological Engineering Revenue in Amino Acid Metabolism Disorder Drug Business (2015-2020)
    • 10.11.5 Shine Star (Hubei) Biological Engineering Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Amino Acid Metabolism Disorder Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Amino Acid Metabolism Disorder Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Arginine
    Folic Acid
    Vitamin B6 & B12
    Thiamine
    Vitamin D
    Betaine
    Carglumic Acid
    Sapropterin Dihydrochloride
    Others

    Market segment by Application, split into
    Phenylketonuria
    Maple Syrup Urine Disease
    Argininosuccinic Acidemia
    Citrullinemia
    Homocystinuria

    Based on regional and country-level analysis, the Amino Acid Metabolism Disorder Drug market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Amino Acid Metabolism Disorder Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    GlaxoSmithKline
    Pfizer
    AMINO
    Merck
    Recordati
    DSM
    Sanofi
    Kyowa Hakko Kirin
    BioMarin
    Swedish Orphan Biovitrum
    Buy now